These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3543606)

  • 21. [Acromegaly].
    Zapf J
    Schweiz Rundsch Med Prax; 1984 Mar; 73(10):293-8. PubMed ID: 6709989
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of somatostatin of plasma levels of glucose, insulin and growth hormone in acromegaly].
    Porzio G; Massara F; Camanni F; Rizzi G; Molinatti GM
    Minerva Med; 1976 Oct; 67(50):3241-2. PubMed ID: 995281
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bromocriptine therapy in acromegaly (author's transl)(proceedings)].
    Schaison G; Mowszowicz I
    Ann Endocrinol (Paris); 1976; 37(4):297-8. PubMed ID: 1037359
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hormonal evaluation of 27 patients with acromegaly].
    Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
    Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acromegaly. 3. Significance of the dynamic study of somatotropin].
    Marek J; Srámková J; Bleha O; Engelberth O
    Cas Lek Cesk; 1973; 112(28):849-53. PubMed ID: 4720439
    [No Abstract]   [Full Text] [Related]  

  • 26. [Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both].
    Barceló B; Pérez C; Dávila N; Lucas T; Salto L; Alcañiz J
    Med Clin (Barc); 1983 May; 80(17):735-41. PubMed ID: 6621120
    [No Abstract]   [Full Text] [Related]  

  • 27. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between suppression of growth hormone by CB-154 and prolactin secretion in acromegaly--indication for a long term care].
    Hara I; Kataoka K; Tomita A; Kuwayama A; Kageyama N
    Horumon To Rinsho; 1977 Dec; 25(12):1316-20. PubMed ID: 413675
    [No Abstract]   [Full Text] [Related]  

  • 30. Acromegaly treated with chlorpromazine. A case study.
    Kolodny HD; Sherman L; Singh A; Kim S; Benjamin F
    N Engl J Med; 1971 Apr; 284(15):819-22. PubMed ID: 5549804
    [No Abstract]   [Full Text] [Related]  

  • 31. Secretin and insulin release in acromegaly.
    Chisholm DJ; Lazarus L; Young JD
    J Clin Endocrinol Metab; 1972 Jul; 35(1):108-12. PubMed ID: 5032508
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin tolerance test and tolbutamide tolerance test in acromegaly.
    Farag Y; Gaafar MA
    J Egypt Med Assoc; 1977; 60(9-12):839-50. PubMed ID: 753863
    [No Abstract]   [Full Text] [Related]  

  • 33. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 34. [Growth hormone and insulin in the blood in pancreatic cancer during the glucose tolerance test].
    Shlimovich PB; Miroshnichenko AG
    Vopr Onkol; 1978; 24(9):88-91. PubMed ID: 706302
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppressibility of plasma growth hormone levels in acromegaly with dexamethasone and phentolamine.
    Nakagawa K; Mashimo K
    J Clin Endocrinol Metab; 1973 Aug; 37(2):238-46. PubMed ID: 4720071
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of medroxyprogesterone acetate (MPA) on the blood level of STH in 12 patients with acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):426-30. PubMed ID: 4664003
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of CB-154 in acromegaly].
    Ishibashi M; Yamaji T
    Horumon To Rinsho; 1977 Dec; 25(12):1292-6. PubMed ID: 598022
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of blood somatotropin and phosphorus levels after administration of 2-bromo-alpha-ergocryptine].
    Romiti A; Martelletti P; Giacovazzo M
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2257-9. PubMed ID: 754723
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of chlorpromazine on serum growth-hormone concentration in man.
    Sherman L; Kim S; Benjamin F; Kolodny HD
    N Engl J Med; 1971 Jan; 284(2):72-4. PubMed ID: 5538637
    [No Abstract]   [Full Text] [Related]  

  • 40. Bromocriptine treatment over 12 years in acromegaly: effect on glucose tolerance and insulin secretion.
    Rau H; Althoff PH; Schmidt K; Badenhoop K; Usadel KH
    Clin Investig; 1993 May; 71(5):372-8. PubMed ID: 8508007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.